IRTC compared with BLTE: revenue, margins and what each company keeps, and the suppliers and customers both name

IRTCiRhythm Holdings, Inc.

Mkt capRevenueRevenue

BLTEBelite Bio, Inc

Mkt capRevenueRevenue

Compare

IRTCiRhythm Holdings, Inc.

BLTEBelite Bio, Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

IRTC: latest quarter is a loss; flow not drawable. BLTE: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only IRTC 16

—the Medicare program through CMSunlistedcustomer

—BioISunlistedsupplier

—Sutherland Healthcare Solutionsunlistedsupplier

—Techindia Infoway Privateunlistedsupplier

12 more · IRTC chain ›

Shared 0

No shared counterparties.

Only BLTE 1

—The Trustees of Columbia University in the City of New Yorkunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

IRTCiRhythm Holdings, Inc.

123.54▲+0.14%· post 126.17

Mkt cap$4.1BRevenue$224MQ2 FY26Revenue$747MFY25

BLTEBelite Bio, Inc

153.60▼−0.74%· post 153.59

ClosedNov 2 '26

Mkt cap$6.0BRevenue—Revenue—

Compare

ClosedNov 2 '26

IRTCiRhythm Holdings, Inc.

BLTEBelite Bio, Inc

123.54▲+0.14%post 126.17

Price

153.60▼−0.74%post 153.59

$4.1B

Mkt cap

$6.0B

Q2 FY26$224M

Revenue

—

FY25$747M

Revenue

—

IRTC123.54▲+0.14%vsBLTE153.60▼−0.74%ClosedNov 2 '26

Price

rebased to 0%

IRTC, solidBLTE, dashed